---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-021752"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T09:59:49.120940+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs 1Q24 revenue $50.6M (+0.4%), net loss $(0.10)/share, AOI up 46% to $9.5M

## Summary
- Revenue $50.6M, +0.4% YoY; core organic growth 2.0% (ex-currency/COVID).
- Operating loss narrowed 85.5% to $(0.7M); net loss $(0.5M) or $(0.10)/share.
- Non-GAAP AOI excluding unusual items rose 46.2% to $9.5M (18.8% of revenue).
- Divisions: Calibration +12.5% core organic, Sterilization +7.2%, Clinical Genomics -4.4%, Biopharma -6.6%.
- Headwinds: slowing capital equipment, Sema4 loss, currency; cost cuts aiding profitability.

## SEC filing metadata
- accession: 0001437749-23-021752
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774923021752/0001437749-23-021752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774923021752/mlab20230802_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-021752
- JSON: https://secwatch.observer/filing/0001437749-23-021752.json
- Plain text: https://secwatch.observer/filing/0001437749-23-021752.txt

## Key facts
- Earnings Releases
  MESA LABORATORIES INC /CO/ reported the three months ended June 30, 2023 results: revenue $50,645, net income $(549), EPS $(0.10) per diluted share.
  - Period: the three months ended June 30, 2023
  - Revenue: $50,645
  - Net income: $(549)
  - EPS: $(0.10) per diluted share
  - Result: reported results
  source text: Total revenues were $50,645, an increase of 0.4% compared to the first quarter of fiscal year 2023 (“1Q23”) as last year’s acquisition of Belyntic made a modest contribution to revenue. Operating loss decreased 85.5% to $ (664). Net loss was $(549), a decrease of 61.8% or $(0.10) per diluted share of common stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/724004/000143774923021752/0001437749-23-021752-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.